Coyne Terrance P. — SEC insider filings

SEC reporting owner CIK 1814876. 35 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 35 filings on record, filed 2021-01-05 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Royalty Pharma plc (RPRX)EVP & CFO35—53 legs · 1,577,523 sh · $73,049,91725

Insider filings — Coyne Terrance P.

FiledFormIssuerReported transactionsSource
2026-11-184Royalty Pharma plc (RPRX)Sale (S): 135,249 @ $68.87 · Sale (S): 14,751 @ $68.30 · Sale (S): 90,165 @ $68.87 · Sale (S): 9,835 @ $68.30 · Sale (S): 7,122 @ $68.87EDGAR
2026-11-064Royalty Pharma plc (RPRX)Grant/award (A): 7,122 @ $0 · Conversion (C): 150,000 @ $0 · Conversion (C): 100,000 @ $0 · Conversion (C): 15,000 (derivative) @ $0 · Conversion (C): 10,000 (derivative) @ $0EDGAR
2026-08-174Royalty Pharma plc (RPRX)Sale (S): 9,230 @ $58.59 · Sale (S): 1,772 @ $59.14EDGAR
2026-08-074Royalty Pharma plc (RPRX)Grant/award (A): 11,002 @ $0 · Gift (G): 18,500 (derivative) @ $0EDGAR
2026-05-284Royalty Pharma plc (RPRX)Sale (S): 64,399 @ $53.98EDGAR
2026-05-084Royalty Pharma plc (RPRX)Grant/award (A): 24,263 @ $0EDGAR
2026-04-304Royalty Pharma plc (RPRX)Sale (S): 32,916 @ $49.78 · Sale (S): 1,875 @ $49.78EDGAR
2026-04-024Royalty Pharma plc (RPRX)Sale (S): 1,875 @ $48.33 · Sale (S): 32,916 @ $48.33EDGAR
2026-03-254Royalty Pharma plc (RPRX)Sale (S): 32,916 @ $45.53 · Sale (S): 1,875 @ $45.53EDGAR
2026-03-044Royalty Pharma plc (RPRX)Sale (S): 22,487 @ $46.67 · Sale (S): 10,429 @ $47.01 · Sale (S): 1,292 @ $46.67 · Sale (S): 583 @ $47.01EDGAR
2026-02-254Royalty Pharma plc (RPRX)Sale (S): 32,916 @ $45.32 · Sale (S): 1,875 @ $45.32EDGAR
2026-02-134Royalty Pharma plc (RPRX)Grant/award (A): 26,626 @ $0EDGAR
2026-02-044Royalty Pharma plc (RPRX)Sale (S): 102,581 @ $42.08 · Sale (S): 108,759 @ $42.84 · Sale (S): 19,076 @ $43.29 · Sale (S): 5,843 @ $42.08 · Sale (S): 6,195 @ $42.84 · Sale (S): 1,087 @ $43.29EDGAR
2026-01-234Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $39.35 · Sale (S): 3,750 @ $39.35EDGAR
2026-01-064Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $38.42 · Sale (S): 3,750 @ $38.42EDGAR
2025-12-174Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $38.36 · Sale (S): 3,750 @ $38.36EDGAR
2025-12-034Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $39.87 · Sale (S): 3,750 @ $39.87EDGAR
2025-11-264Royalty Pharma plc (RPRX)Sale (S): 55,146 @ $38.67 · Sale (S): 10,686 @ $37.96 · Sale (S): 3,126 @ $38.67 · Sale (S): 624 @ $37.96EDGAR
2025-11-194Royalty Pharma plc (RPRX)Sale (S): 65,844 @ $39.30 · Sale (S): 3,750 @ $39.30EDGAR
2025-11-074Royalty Pharma plc (RPRX)Grant/award (A): 6,168 @ $0EDGAR
2025-08-084Royalty Pharma plc (RPRX)Grant/award (A): 3,696 @ $0 · Gift (G): 1,000 (derivative) @ $0EDGAR
2025-05-204Royalty Pharma plc (RPRX)Grant/award (A): 1,807,277 (derivative) @ $0EDGAR
2025-05-094Royalty Pharma plc (RPRX)Grant/award (A): 48,646 @ $0EDGAR
2024-08-124Royalty Pharma plc (RPRX)Gift (G): 2,000 (derivative) @ $0EDGAR
2023-08-114Royalty Pharma plc (RPRX)Sale (S): 37,500 @ $30.72 · Sale (S): 37,500 @ $30.75EDGAR
2023-08-084Royalty Pharma plc (RPRX)Gift (G): 1,650 (derivative) @ $0EDGAR
2023-07-144Royalty Pharma plc (RPRX)Sale (S): 37,500 @ $31.07 · Sale (S): 37,500 @ $30.93EDGAR
2022-11-104Royalty Pharma plc (RPRX)Sale (S): 24,500 @ $43.47EDGAR
2022-11-044Royalty Pharma plc (RPRX)Sale (S): 5,500 @ $43.06EDGAR
2022-08-034Royalty Pharma plc (RPRX)Sale (S): 30,000 @ $43.19EDGAR
2021-05-114Royalty Pharma plc (RPRX)Conversion (C): 1,000,000 @ $0 · Conversion (C): 100,000 (derivative) @ $0EDGAR
2021-03-054Royalty Pharma plc (RPRX)Sale (S): 29,820 @ $43.71 · Sale (S): 57,723 @ $45.09 · Sale (S): 11,001 @ $45.86 · Sale (S): 1,456 @ $46.83EDGAR
2021-03-044Royalty Pharma plc (RPRX)Sale (S): 94,978 @ $46.89 · Sale (S): 5,022 @ $47.88EDGAR
2021-01-054/ARoyalty Pharma plc (RPRX)Conversion (C): 24,170 @ $0 · Grant/award (A): 2,605 (derivative) @ $0 · Conversion (C): 2,417 (derivative) @ $0EDGAR
2021-01-054Royalty Pharma plc (RPRX)Conversion (C): 99,770 @ $0 · Conversion (C): 300,230 @ $0 · Conversion (C): 9,977 (derivative) @ $0 · Conversion (C): 30,023 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1814876 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs